Safety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-198
Clinical trial NCT04479644 · COMPLETED
Trial details
- NCT number
- NCT04479644
- Sponsor
- Brii Biosciences Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-13
- Primary completion
- 2021-02-03
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.